LATEST PRICE
$22.95
H 23.98 · L 22.78
Vol 7.8M · May 18
COMPOSITE SCORE
46.4
out of 100
RECOMMENDATION
IGNORE
CONFIDENCE
72%
MODULES RUN
8/8
May 18, 14:14 UTC
Top Signals
- • CEO assessment: CEO has shown resilience in challenging market conditions but lacks a long-term track record.
- • Insider ownership: Moderate
- • Recent strategic acquisitions indicate proactive growth strategy.
- • Strong focus on telehealth and consumer brand development.
- • Moderate insider ownership aligns interests but not significantly high.
Price History
showing 7 of 30 days
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| May 18, 2026 | $23.98 | 23.98 | 22.78 | $22.95 | -2.10 (-8.4%) | 7.8M |
| May 15, 2026 | $23.68 | 25.32 | 23.53 | $25.05 | +0.81 (+3.3%) | 20.6M |
| May 14, 2026 | $24.04 | 24.80 | 23.38 | $24.24 | +0.10 (+0.4%) | 18.3M |
| May 13, 2026 | $24.51 | 24.89 | 23.26 | $24.14 | -0.89 (-3.6%) | 26.0M |
| May 12, 2026 | $25.21 | 26.84 | 24.56 | $25.03 | -4.11 (-14.1%) | 53.6M |
| May 11, 2026 | $29.09 | 30.39 | 28.55 | $29.14 | +0.87 (+3.1%) | 61.2M |
| May 08, 2026 | $25.61 | 28.53 | 25.40 | $28.27 | +2.62 (+10.2%) | 26.0M |
Module Breakdown — May 18, 14:14 UTC
| Module | Score | Confidence | Signals |
|---|---|---|---|
| Moat |
65.0 |
65% | • Switching costs: Low | Network effects: Moderate • Brand strength: Moderate | Market position: Competitive • Growing telehealth market • Brand recognition among millennials • Low barriers to entry • Dependence on regulatory approvals |
| Leadership |
65.0 |
65% | • CEO assessment: CEO has shown resilience in challenging market conditions but lacks a long-term track record. • Insider ownership: Moderate • Recent strategic acquisitions indicate proactive growth strategy. • Strong focus on telehealth and consumer brand development. • Moderate insider ownership aligns interests but not significantly high. • Past governance concerns raised during rapid expansion phase. |
| FinancialHealth |
52.0 |
85% | • Unprofitable: Net loss $92M • Positive revenue growth QoQ: +1.5% • Positive free cash flow: $89M |
| Institutional |
50.0 |
40% | • No insider transactions found in last 90 days (SEC EDGAR Form 4) |
| Valuation |
50.0 |
78% | • P/E ratio unavailable (negative earnings) |
| Macro |
50.0 |
15% | • Sector performance data unavailable |
| Sentiment |
27.0 |
32% | • Analysed 5 articles over 7 days (4 sentiment-scored) • Average sentiment: -0.38 — Positive: 1, Neutral: 0, Negative: 3 • Most bullish: "Is Hims and Hers Health Stock a Buy After Its Latest Dip?" (score +0.50) • Most bearish: "Why Hims & Hers Health Stock Just Crashed" (score -+0.80) • Sentiment cluster: 3 negative vs 1 positive articles — bearish consensus (-8 penalty) |
| Momentum |
23.0 |
95% | • Death cross: MA50 (24.31) < MA200 (35.64) • RSI approaching oversold: 35.4 • MACD bearish: -0.9474 < signal -0.1136 • Weak 20-day momentum: -22.9% |
Score History
showing 7 of 30 runs
| Date (UTC) | Score | Recommendation | Confidence | Modules |
|---|---|---|---|---|
| May 18, 14:14 | 46.4 | IGNORE | 72% | 8 |
| May 17, 09:12 | 46.4 | IGNORE | 72% | 8 |
| May 16, 12:23 | 46.7 | IGNORE | 72% | 8 |
| May 15, 11:13 | 46.9 | IGNORE | 73% | 8 |
| May 14, 10:07 | 46.4 | IGNORE | 72% | 8 |
| May 13, 09:13 | 48.8 | IGNORE | 72% | 8 |
| May 12, 09:41 | 49.0 | IGNORE | 71% | 8 |